Furthermore, studies suggest that at high levels, there are reports that pro-inflammatory and atherosclerosis signaling factors, including MMP-9, were associated with a significantly higher risk of adverse clinical outcomes. The gene discussed is MMP9; the disease is atherosclerosis.